How to Navigate Buprenorphine Discontinuation

Saturday, April 6, 2024

10:30 AM – 11:45 AM

Presenter(s)

Kento Sonoda, MD, AAHIVS, FASAM

Assistant Professor
Saint Louis University, Missouri

Slides Handouts
JB

Jennifer Bello Kottenstette, MD, MS, FASAM

Associate Professor
Saint Louis University, Missouri
Jacob P. Scheer, MD

Addiction Medicine Fellow
Saint Louis University, Illinois
AH

Amy B. Hilmer, MD

Director of Inpatient Addiction Medicine Consult Service
SLU, Missouri

Please join our highly interactive session and gain vital insights into the field of opioid use disorder treatment. Explore various reasons patients express interest in discontinuing buprenorphine, despite its proven benefits. Our session covers the challenges and misconceptions surrounding long-term buprenorphine use. Participants learn practical strategies for facilitating conversations with patients about tapering off buprenorphine through role plays and small group activities. You will be equipped with the tools to address this critical aspect of addiction medicine.

Learning Objectives:

Learners will be able to:

Identify at least three common misconceptions regarding buprenorphine discontinuation
Demonstrate practical skills for facilitating the conversation about buprenorphine discontinuation
Apply at least one strategy to taper off buprenorphine